GeneDx Holdings (WGS) Current Deferred Revenue (2020 - 2022)
GeneDx Holdings (WGS) posted quarterly Current Deferred Revenue of $40000.0 for Q4 2022, down 91.54% year-over-year from $473000.0 in Q4 2021, and down 39.39% quarter-over-quarter from $66000.0 in Q1 2022.
GeneDx Holdings (WGS) Current Deferred Revenue (2020 - 2022) Analysis & Trends
GeneDx Holdings (WGS) has reported Current Deferred Revenue for 3 consecutive years, with $40000.0 the latest figure, recorded in Q4 2022.
- In Q4 2022, Current Deferred Revenue fell 91.54% year-over-year to $40000.0; the TTM figure through Dec 2022 stood at $40000.0 (down 91.54% YoY), while the FY2022 annual figure was $40000.0, down 91.54% from the prior year.
- Current Deferred Revenue eased to $40000.0 in Q4 2022 per WGS's latest filing, from $66000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $2.8 million in Q1 2021 and bottomed at $40000.0 in Q4 2022.
- Historically, Current Deferred Revenue has averaged $1.0 million across 3 years, with a median of $493000.0 in 2021.
- Annual changes were most pronounced in 2021 — Current Deferred Revenue plunged 73.47% — and 2022, when it sank 97.65%.
- GeneDx Holdings' Current Deferred Revenue stood at $1.8 million in 2020, then plunged by 73.47% to $473000.0 in 2021, then plunged by 91.54% to $40000.0 in 2022.
- Business Quant data shows WGS's Current Deferred Revenue at $40000.0 in Q4 2022, $66000.0 in Q1 2022, and $473000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 40,000.00 |
| Mar 31, 2022 | 66,000.00 |
| Dec 31, 2021 | 473,000.00 |
| Sep 30, 2021 | 493,000.00 |
| Jun 30, 2021 | 1.34 Mn |
| Mar 31, 2021 | 2.81 Mn |
| Dec 31, 2020 | 1.78 Mn |